- Headquarters
- Tokyo, Japan · East Asia
- Value chain
- Research & IP(Research & design)
- What that means
- Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
- Founded
- 2005
- Ownership
- Listed
- Listing
- TSE:4568 on Google Finance
- Website
- daiichisankyo.com
- Relevance
- Low at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
Tokyo, JapanIn 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #23 of 50
Developed Daichirona, Japan's domestically approved mRNA COVID-19 vaccine, and leads in antibody-drug conjugates (Enhertu).
Relevance: Japan-only mRNA vaccine